GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Monash IVF Group Ltd (FRA:MIS) » Definitions » Equity-to-Asset

Monash IVF Group (FRA:MIS) Equity-to-Asset : 0.49 (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Monash IVF Group Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Monash IVF Group's Total Stockholders Equity for the quarter that ended in Dec. 2024 was €150.9 Mil. Monash IVF Group's Total Assets for the quarter that ended in Dec. 2024 was €307.1 Mil. Therefore, Monash IVF Group's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was 0.49.

The historical rank and industry rank for Monash IVF Group's Equity-to-Asset or its related term are showing as below:

FRA:MIS' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.48   Med: 0.58   Max: 0.77
Current: 0.49

During the past 11 years, the highest Equity to Asset Ratio of Monash IVF Group was 0.77. The lowest was 0.48. And the median was 0.58.

FRA:MIS's Equity-to-Asset is ranked worse than
62.73% of 220 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.625 vs FRA:MIS: 0.49

Monash IVF Group Equity-to-Asset Historical Data

The historical data trend for Monash IVF Group's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monash IVF Group Equity-to-Asset Chart

Monash IVF Group Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.72 0.76 0.70 0.65 0.48

Monash IVF Group Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 0.65 0.61 0.48 0.49

Competitive Comparison of Monash IVF Group's Equity-to-Asset

For the Diagnostics & Research subindustry, Monash IVF Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Monash IVF Group's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Monash IVF Group's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Monash IVF Group's Equity-to-Asset falls into.


;
;

Monash IVF Group Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Monash IVF Group's Equity to Asset Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Equity to Asset (A: Jun. 2024 )=Total Stockholders Equity/Total Assets
=149.223/313.658
=0.48

Monash IVF Group's Equity to Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

Equity to Asset (Q: Dec. 2024 )=Total Stockholders Equity/Total Assets
=150.932/307.062
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Monash IVF Group  (FRA:MIS) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Monash IVF Group Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Monash IVF Group's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Monash IVF Group Business Description

Traded in Other Exchanges
Address
510 Church Street, Level 1, Cremorne, Cremorne, VIC, AUS, 3121
Monash IVF Group Ltd is a specialist assisted reproductive services provider. The company offers specialist diagnostic obstetric and gynaecological ultrasound and fertility treatments. The company's operating segment includes Australia IVF and International IVF. It generates maximum revenue from the Australian segment. Australian segment is a provider of Assisted Reproductive Services, Ultrasound, and other related services. The International segment is a provider of Assisted Reproductive Services in Malaysia. Maximum revenue is earned from Australia IVF and Ultrasound.

Monash IVF Group Headlines

No Headlines